Bridgewater Associates’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-21,118
| Closed | -$238K | – | 718 |
|
|
2024
Q4 | $238K | Sell |
21,118
-51,380
| -71% | -$578K | ﹤0.01% | 660 |
|
|
2024
Q3 | $2.05M | Sell |
72,498
-80,387
| -53% | -$2.27M | 0.01% | 504 |
|
|
2024
Q2 | $2.92M | Sell |
152,885
-22,854
| -13% | -$437K | 0.02% | 462 |
|
|
2024
Q1 | $5.76M | Sell |
175,739
-28,638
| -14% | -$939K | 0.03% | 358 |
|
|
2023
Q4 | $6.75M | Sell |
204,377
-18,590
| -8% | -$614K | 0.04% | 321 |
|
|
2023
Q3 | $6.07M | Buy |
222,967
+16,453
| +8% | +$448K | 0.04% | 323 |
|
|
2023
Q2 | $6.26M | Sell |
206,514
-8,963
| -4% | -$272K | 0.04% | 262 |
|
|
2023
Q1 | $6.99M | Buy |
215,477
+19,542
| +10% | +$634K | 0.04% | 250 |
|
|
2022
Q4 | $5.5M | Sell |
195,935
-37,800
| -16% | -$1.06M | 0.03% | 343 |
|
|
2022
Q3 | $8.4M | Sell |
233,735
-6,806
| -3% | -$245K | 0.04% | 282 |
|
|
2022
Q2 | $7.39M | Buy |
240,541
+13,705
| +6% | +$421K | 0.03% | 395 |
|
|
2022
Q1 | $7.33M | Buy |
226,836
+56,491
| +33% | +$1.82M | 0.03% | 369 |
|
|
2021
Q4 | $4.71M | Buy |
170,345
+18,245
| +12% | +$505K | 0.03% | 311 |
|
|
2021
Q3 | $4.72M | Sell |
152,100
-6,413
| -4% | -$199K | 0.03% | 295 |
|
|
2021
Q2 | $3.35M | Buy |
+158,513
| New | +$3.35M | 0.02% | 407 |
|